Celik Tellioglu Emine, Oncul Ahsen, Diktas Husrev, Atasoy Tahtasakal Ceren, Aktas Elif, Genc Yaman Irem, Yildiz Sevgi Dilek, Dokmetas Ilyas
Department of Infectious Diseases, University of Health Sciences Türkiye, Gaziosmanpasa Training and Research Hospital, Istanbul, Türkiye.
Department of Infectious Diseases, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Sisli Etfal Hastan Tip Bul. 2024 Sep 30;58(3):371-380. doi: 10.14744/SEMB.2024.26096. eCollection 2024.
The role of hematologic, inflammatory and biochemical parameters as biomarkers, their role in identifying risky patients in the early stage and their role in prognosis in COVID-19 Coronavirus disease 2019 (COVID-19) were investigated.
The study included patients who were hospitalized and followed up with a prediagnosis of COVID-19 in the first wave in our country at the University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital Demographic and clinical characteristics as well as complete blood count, C reactive protein (CRP), procalcitonin (PCT), fibrinogen (FIB), ferritin, albumin (ALB), lactate dehydrogenase (LDH) levels on admission, third, seventh and 14th days were analyzed. Patients were grouped and compared according to the occurrence of death during hospital follow-up. Variables considered significant on mortality were analyzed with univariate and multivariate logistic regression models.
The study was conducted with 485 patients, 273 (56.3%) males and 212 (43.72%) females. The mean age of the patients was 58±16.2 years, and 71% were in the mild-moderate and 29% in the severe-critical disease group. Disease severity, the need for intensive care unit (ICU) follow-up, and the development of death were positively correlated with age, comorbidity, neutrophil (NE), leukocyte, neutrophil-lymphocyte ratio (NLR), PCT, CRP, ferritin, LDH values, and negatively correlated with lymphocyte (LE), ALB and hemoglobin (HGB) values. In multivariate analysis, elevated PCT at hospital admission (OR: 6.96 [1.63;39.65]), LDH ≥ 352U/L (OR: 4.35 [1.23;16.61]), LE<0.810 × 109/L (OR: 3.0 [1.16;7.85]) and advanced age (OR: 1.08 [1.03;1.14]) were independently associated with in-hospital death. In hemogram and acute phase reactant monitoring, PCT, CRP and LDH were the most valuable markers for predicting death, respectively (third-day AUC: 0.90;0.83;0.83 and seventh-day AUC: 0.95;0.90;0.89, respectively).
In our study, leukocytes, lymphocytes, NLR, CRP, PCT, ferritin, albumin and LDH at admission were valuable in predicting poor prognosis. In addition, it was determined that increases in PCT, LDH and CRP during follow-up could be used to predict in-hospital death and to identify patients requiring close follow-up.
研究血液学、炎症和生化参数作为生物标志物的作用,它们在早期识别高危患者中的作用以及在2019冠状病毒病(COVID-19)预后中的作用。
该研究纳入了在我国第一波疫情期间于健康科学大学锡斯利哈米迪耶埃特法尔培训与研究医院住院并在确诊COVID-19之前接受随访的患者。分析了人口统计学和临床特征以及入院时、第三天、第七天和第十四天的全血细胞计数、C反应蛋白(CRP)、降钙素原(PCT)、纤维蛋白原(FIB)、铁蛋白、白蛋白(ALB)、乳酸脱氢酶(LDH)水平。根据医院随访期间的死亡情况对患者进行分组并比较。对死亡率有显著影响的变量采用单因素和多因素逻辑回归模型进行分析。
该研究共纳入485例患者,其中男性273例(56.3%),女性212例(43.72%)。患者的平均年龄为58±16.2岁,71%为轻-中度疾病组,29%为重度-危重症疾病组。疾病严重程度、重症监护病房(ICU)随访需求和死亡的发生与年龄、合并症、中性粒细胞(NE)、白细胞、中性粒细胞-淋巴细胞比值(NLR)、PCT、CRP、铁蛋白、LDH值呈正相关,与淋巴细胞(LE)、ALB和血红蛋白(HGB)值呈负相关。多因素分析显示,入院时PCT升高(比值比:6.96[1.63;39.65])、LDH≥352U/L(比值比:4.35[1.23;16.61])、LE<0.810×10⁹/L(比值比:3.0[1.16;7.85])和高龄(比值比:1.08[1.03;1.14])与院内死亡独立相关。在血常规和急性期反应物监测中,PCT、CRP和LDH分别是预测死亡最有价值的标志物(第三天曲线下面积:0.90;0.83;0.83,第七天曲线下面积:0.95;0.90;0.89)。
在我们的研究中,入院时的白细胞、淋巴细胞、NLR、CRP、PCT、铁蛋白、白蛋白和LDH对预测不良预后有价值。此外,还确定随访期间PCT、LDH和CRP的升高可用于预测院内死亡并识别需要密切随访的患者。